BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11719429)

  • 1. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
    Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
    Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
    Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
    Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
    Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWOX, the common chromosomal fragile site, FRA16D, cancer gene.
    Ludes-Meyers JH; Bednarek AK; Popescu NC; Bedford M; Aldaz CM
    Cytogenet Genome Res; 2003; 100(1-4):101-10. PubMed ID: 14526170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Shiraishi T; Alder H; Mimori K; Mori M; Croce CM
    Cancer Res; 2002 Apr; 62(8):2258-60. PubMed ID: 11956080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An opposing view on WWOX protein function as a tumor suppressor.
    Watanabe A; Hippo Y; Taniguchi H; Iwanari H; Yashiro M; Hirakawa K; Kodama T; Aburatani H
    Cancer Res; 2003 Dec; 63(24):8629-33. PubMed ID: 14695174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WWOX: a candidate tumor suppressor gene involved in multiple tumor types.
    Paige AJ; Taylor KJ; Taylor C; Hillier SG; Farrington S; Scott D; Porteous DJ; Smyth JF; Gabra H; Watson JE
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11417-22. PubMed ID: 11572989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WWOX, the tumour suppressor gene affected in multiple cancers.
    Lewandowska U; Zelazowski M; Seta K; Byczewska M; Pluciennik E; Bednarek AK
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():47-56. PubMed ID: 19609013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
    Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK
    Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common chromosomal fragile site FRA16D mutation in cancer cells.
    Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
    Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.